Brad Pick Highlights PPTA’s Insights on Plasma Therapies for Trauma, Surgery and Chronic Illnesses
Brad Pick, Senior Director Global External Communications at Grifols, shared a post by Plasma Protein Therapeutics Association (PPTA) on LinkedIn:
”What many don’t realize is that plasma therapeutics treat more than rare and chronic diseases. They have a vital role in treating everyday medical situations such as trauma and major surgery. That’s something all of us can relate to.”
Quoting Plasma Protein Therapeutics Association (PPTA)‘s post:
”Using specialized techniques, pooled plasma is separated and purified, and each protein undergoes advanced processes for therapeutic safety.
These manufacturing steps lead to plasma-derived medicines, such as albumin, immunoglobulins, coagulation factors, C1 esterase inhibitors, and Alpha-1 proteinase inhibitors.
These plasma-derived medicines are used to treat a range of conditions, from immunodeficiencies to blood clotting disorders, highlighting the critical role plasma proteins play in a variety of conditions – more of which are being discovered every day.
Learn more about the journey of plasma-derived medicines on our YouTube channel.”
See the Plasma Protein Therapeutics Association (PPTA) post here.
Stay updated with Hemostasis Today.
-
Jul 8, 2026, 11:33Ifeanyichukwu Ifechidere: Haemophilia A and B – From First Diagnosis to the Era of Gene Therapy
-
Jul 8, 2026, 10:29Bringing Hemophilia Care Closer to Communities in Togo – WFH
-
Jul 8, 2026, 10:12Natasha Jolakoski: Completing Advanced Training in Thrombosis and Hemostasis
-
Jul 8, 2026, 09:58Rola Ghasoub: Early Intracranial Hemorrhage Remains the Main Barrier to Cure in Acute Promyelocytic Leukemia
-
Jul 8, 2026, 05:53Excellent PhD Defense by Roberta Cirsmaru on Gene Therapy for Hemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Jul 8, 2026, 05:48Riccardo Menandro: How Lipid Nanoparticles Are Shaping the Future of Rare Disease and Hemophilia Treatment
-
Jul 8, 2026, 05:39Daniel Victor Ortigoza: New Evidence from ATLANTIS-4D-CT on Apixaban and Subclinical Valve Thrombosis
-
Jul 8, 2026, 04:50Reza Bavarsad Shahripour: New AHA Guidance on Cryptogenic Stroke with Reduced Left Ventricular Function
-
Jul 7, 2026, 23:20Balaji Balagani: Exploring Pulmonary Embolism